Because of the COVID-19 epidemic, we were unfortunately forced to cancel our second face-to-face meeting in Tenerife in March 2020. In stead of the face-to-face meeting, we organised an online videoconference which was a great success! We achieved consensus on the final assessment blueprint, the European Drug List and first 30 question items.